OMNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Outset Medical, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$3.80−0.14 (-3.55%)
Close on Oct 19, 2026
- Market cap
- $70.75K
- P/E (TTM)
- –
- Dividend yield
- –
Outset Medical, Inc. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| Product Revenue | $84.81M | $80.98M | $103.54M | $93.39M | $84.31M | $39.61M | $13.75M | $1.75M | 71.0% | +4.7% |
| Consumables Product | $54.08M | $51.15M | $42.21M | $28.80M | $19.18M | $6.74M | $1.56M | $523.00K | 45.3% | +5.7% |
| Service and Other Revenue | $34.67M | $32.71M | $26.84M | $21.99M | $18.29M | $10.32M | $1.33M | $258.00K | 29.0% | +6.0% |
| Consoles Product | $30.73M | $29.83M | $61.33M | $64.59M | $65.13M | $32.87M | $12.19M | $1.23M | 25.7% | +3.0% |
By region
From the segment and revenue-disaggregation notes of Outset Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.